PSMB9 and B-cell neoplasm: Mutation spectrum analysis based on the TCGA pan-cancer dataset revealed that the proportion of PSMB9 alterations was highest in mature B-cell neoplasms, approximately 8%, with deep deletion being the predominant type, accounting for about 3/4 of all alterations (Figure 3A).